These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Expression profile of malignant and non-malignant diseases of the thyroid gland reveals altered expression of a common set of genes in goiter and papillary carcinomas. Stolf BS; Abreu CM; Mahler-Araújo MB; Dellamano M; Martins WK; de Carvalho MB; Curado MP; Díaz JP; Fabri A; Brentani H; Carvalho AF; Soares FA; Kowalski LP; Hirata R; Reis LF Cancer Lett; 2005 Sep; 227(1):59-73. PubMed ID: 16051032 [TBL] [Abstract][Full Text] [Related]
10. Expression of heregulins and associations with the ErbB family of tyrosine kinase receptors in papillary thyroid carcinomas. Fluge O; Akslen LA; Haugen DR; Varhaug JE; Lillehaug JR Int J Cancer; 2000 Sep; 87(6):763-70. PubMed ID: 10956383 [TBL] [Abstract][Full Text] [Related]
11. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer. Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345 [TBL] [Abstract][Full Text] [Related]
12. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas. Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135 [TBL] [Abstract][Full Text] [Related]
13. Gene profiling reveals specific oncogenic mechanisms and signaling pathways in oncocytic and papillary thyroid carcinoma. Baris O; Mirebeau-Prunier D; Savagner F; Rodien P; Ballester B; Loriod B; Granjeaud S; Guyetant S; Franc B; Houlgatte R; Reynier P; Malthiery Y Oncogene; 2005 Jun; 24(25):4155-61. PubMed ID: 15806164 [TBL] [Abstract][Full Text] [Related]
14. The helix-loop-helix protein, Id-1, is overexpressed and regulates growth in papillary thyroid cancer. Kebebew E; Treseler PA; Duh QY; Clark OH Surgery; 2003 Aug; 134(2):235-41. PubMed ID: 12947323 [TBL] [Abstract][Full Text] [Related]
15. The expression and role of serum response factor in papillary carcinoma of the thyroid. Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551 [TBL] [Abstract][Full Text] [Related]
16. A metabolic phenotype based on mitochondrial ribosomal protein expression as a predictor of lymph node metastasis in papillary thyroid carcinoma. Lee J; Seol MY; Jeong S; Lee CR; Ku CR; Kang SW; Jeong JJ; Shin DY; Nam KH; Lee EJ; Chung WY; Jo YS Medicine (Baltimore); 2015 Jan; 94(2):e380. PubMed ID: 25590838 [TBL] [Abstract][Full Text] [Related]
17. Heterogeneous distribution of thyrotrophin receptor messenger ribonucleic acid (TSH-R mRNA) in papillary thyroid carcinomas detected by in situ hybridization. Tanaka K; Inoue H; Miki H; Komaki K; Monden Y Clin Endocrinol (Oxf); 1996 Mar; 44(3):259-67. PubMed ID: 8729520 [TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays. Zhao J; Leonard C; Brunner E; Gemsenjäger E; Heitz PU; Odermatt B Int J Oncol; 2006 Nov; 29(5):1041-51. PubMed ID: 17016634 [TBL] [Abstract][Full Text] [Related]